Fleckenstein, Monika
Keenan, Tiarnán D. L. http://orcid.org/0000-0002-2253-1772
Guymer, Robyn H. http://orcid.org/0000-0002-9441-4356
Chakravarthy, Usha http://orcid.org/0000-0002-2606-3734
Schmitz-Valckenberg, Steffen
Klaver, Caroline C.
Wong, Wai T.
Chew, Emily Y. http://orcid.org/0000-0003-0999-9802
Article History
Accepted: 23 March 2021
First Online: 6 May 2021
Competing interests
: M.F. reports grants from Heidelberg Engineering, Genentech/Roche, Novartis and Optos; and personal fees from Bayer, Heidelberg Engineering, Genentech/Roche and Novartis; and non-financial support from Heidelberg Engineering, Optos and Zeiss Meditech, outside the submitted work. In addition, M.F. has a patent, US20140303013 A1, pending. R.H.G serves on the advisory boards of Apellis, Bayer, Genentech/Roche and Novartis. U.C. reports personal fees from Apellis, Alimera, Boehringer Ingelheim, Iveric Bio, Novartis, and Roche. S.S.-V. reports grants from Acucela/Kubota Vision, grants and personal fees from Allergan, personal fees from Bayer, non-financial support from Carl Zeiss MediTec, non-financial support from Centervue, personal fees from Gailmedix, personal fees and non-financial support from Heidelberg Engineering, grants from Katairo, grants and personal fees from Novartis, grants and personal fees from Roche, personal fees from Oxurion, grants and personal fees from Bioeq/Formycon, personal fees from Apellis, grants from SparingVision, grants from Pixium, outside the submitted work. E.Y.C., T.D.L.K and W.T.W. are co-inventors on a patent application (‘Methods and systems for predicting rates of progression of age-related macular degeneration’). W.T.W. is a current employee at Janssen Research and Development. C.C.K. declares no competing interests.